| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.8M | -15.1% |
| R&D Expense | $75.5M | +7.4% |
| SG&A Expense | $24.3M | -20.3% |
| Operating Income | -$96.6M | +2.0% |
| Pre-tax Income | -$96.2M | +2.0% |
| Income Tax | $70K | +118.4% |
| Net Income | -$96.3M | +1.6% |
| EPS (Basic) | -$1.24 | +30.3% |
| EPS (Diluted) | -$1.24 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $209.2M | +170.6% |
| Accounts Receivable | $0 | — |
| Current Assets | $223.1M | +95.0% |
| Total Assets | $246.5M | +68.0% |
| Current Liabilities | $29.5M | -6.0% |
| Long-term Debt | $510K | +0.0% |
| Total Liabilities | $52.1M | +9.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.7M | +48.6% |
| Capital Expenditures | $754K | -17.1% |
| Investing Cash Flow | -$100K | +76.9% |
| Financing Cash Flow | $194.1M | — |
| Free Cash Flow | -$56.4M | +48.3% |
| +30.3% |
| Stockholders' Equity |
| $194.5M |
| +95.9% |